A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms

Exclusion Criteria

• •Any ocular surgery or use of topical antibiotics or antiseptics in either eye within the last 3 months
• •Use of topical steroids, or non-steroidal anti inflammatory drugs in either eye within 30 days of Baseline (or anticipated during the study)
• •Use of lid scrubs within 7 days of Baseline in either eye (or anticipated use during the study)